But phosphorylation level of p38 MAPK induced by BLyS did not increase significantly as compared to the control. It suggested that inhibition by SB 202190 could be through another mechanism and BLyS-independent. In short, BLyS probably promoted breast cancer cell migration via Akt pathways. Figure 4 Activation of Akt protein involved in BLyS-enhanced cell migration. (A) Decreased number of migrated MDA-MB-435 cells was examined when the cells were treated with API-1 (10 μM) and SB 202190 (5 μM) for 8 h (original magnification 200 ×). Data were means of triplicate samples with ± SD; vs 2% FBS, **, P < 0.01; vs BLyS (10 ng/ml),
###, P < 0.001. (B) Phosphorylation of Akt and p38 MAPK proteins in MDA-MB-435 cells by Western Blotting analysis. (C) MDA-MB-435 cells were challenged with API-1 and SB 202190 for 4 h. API-1 inhibited the BLyS-induced selleck (10 ng/ml) phosphorylation of Akt. Discussion We initially demonstrated that hypoxia modulated the expressions of BLyS and its receptors in human breast cancer cell lines. Our data also indicated enhanced breast cancer cell migration in response to BLyS in vitro. BlyS, an immunopotentiator, might be a potential therapeutic target in breast cancer treatment base on this study, but care should be taken for
using immunopotentiator in cancer treatment. Cancer tissues consist of large amounts of mesenchymal cells including fibroblasts, endothelial cells, adipocytes as well as inflammatory cells. As we know, inflammatory cells are a major source of BLyS, suggesting that BLyS may act as a connection between inflammatory cells and cancer cells. Furthermore, growing evidences show that cancer can evolve from chronic inflammation [16]. LXH254 in vivo Inflammation often accompanies cancer and recruits inflammatory cells which release plenty of inflammatory factors [17]. In addition, cancer-associated fibroblasts mediate cancer-enhancing inflammation [18]. Despite the relationship between inflammation and cancer is still poorly understood, Aurora Kinase it is believed that inflammatory cells are not the “”street sweeper”" in cancer tissues all along, but may trigger
cancer progression [19]. Many other processes, such as EMT, are involved in the transition from inflammation to cancer [20]. It is prospected that an advanced breast cancer treatment could be developed if this field is much deeply explored. Previous study reported that NF-kappa B played a key role in the transition from inflammation to cancer [21]. Cancer with NF-kappa B activity usually shows increased resistance to chemotherapy [22]. Furthermore, NF-kappa B is required for the expressions of many inflammatory genes [23]. Curcumin inhibited BLyS AICAR solubility dmso expression by decreasing the nuclear translocation of p65 in B lymphocyte cell lines [10]. Regarding HIF-1α, its protein level is extremely low in normoxic conditions. HIF-1α protein accumulates under hypoxia and regulates the target genes [8]. Interestingly, NF-kappa B also activates angiogenesis encoding genes HIF-1α and VEGF [24, 25].